Cargando…
Promising New Wart Treatment: A Randomized, Placebo-Controlled, Clinical Trial
BACKGROUND: Warts are common dermatological lesion caused by skin epithelial cells’ infection with human Papillomavirus (HPV). OBJECTIVES: This study aimed to assess the efficacy of a new method for the treatment of dermal warts. PATIENTS AND METHODS: In this clinical trial study, 60 patients (older...
Autores principales: | Zandi, Shokrollah, Ahmad Zadeh, Razyeh, Yousefi, Sayedeh Reyhaneh, Gharibi, Fardin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056593/ https://www.ncbi.nlm.nih.gov/pubmed/27761268 http://dx.doi.org/10.5812/ircmj.19650 |
Ejemplares similares
-
Effects of Cabergoline administration on uterine perfusion in women with polycystic ovary syndrome
por: Mohammadbygi, Robabeh, et al.
Publicado: (2013) -
Cryotherapy plus oral zinc sulfate versus cryotherapy plus placebo to treat common warts: A double blind, randomized, placebo-controlled trial()()
por: Mahmoudi, H., et al.
Publicado: (2017) -
Terbinafin 1% Cream and Ketoconazole 2% Cream in the Treatment of Pityriasis Versicolor: A randomized comparative clinical trial
por: Rad, Farrokh, et al.
Publicado: (2014) -
Switching between intralesional antigens: A promising therapeutic approach for recalcitrant warts
por: Nofal, Ahmad, et al.
Publicado: (2020) -
A randomized controlled proof‐of‐concept trial of digoxin and furosemide in adults with cutaneous warts
por: Rijsbergen, M., et al.
Publicado: (2019)